37 related articles for article (PubMed ID: 19500993)
1. Synthesis and evaluation of novel pyrroles and pyrrolopyrimidines as anti-hyperglycemic agents.
Mohamed MS; Ali SA; Abdelaziz DH; Fathallah SS
Biomed Res Int; 2014; 2014():249780. PubMed ID: 25054134
[TBL] [Abstract][Full Text] [Related]
2. The synthetic and therapeutic expedition of isoxazole and its analogs.
Agrawal N; Mishra P
Med Chem Res; 2018; 27(5):1309-1344. PubMed ID: 32214770
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel isoxazole tethered quinone-amino Acid hybrids.
Ravi Kumar P; Behera M; Sambaiah M; Kandula V; Payili N; Jaya Shree A; Yennam S
J Amino Acids; 2014; 2014():721291. PubMed ID: 25709839
[TBL] [Abstract][Full Text] [Related]
4. Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Bhatia G; Srivastava AK
Bioorg Med Chem Lett; 2009 Nov; 19(22):6447-51. PubMed ID: 19811915
[TBL] [Abstract][Full Text] [Related]
5. Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities.
Kumar A; Ahmad P; Maurya RA; Singh AB; Srivastava AK
Eur J Med Chem; 2009 Jan; 44(1):109-16. PubMed ID: 18436346
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
[TBL] [Abstract][Full Text] [Related]
7. Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
Chaturvedi D; Ray S; Srivastava AK; Chander R
Bioorg Med Chem; 2008 Mar; 16(5):2489-98. PubMed ID: 18083521
[TBL] [Abstract][Full Text] [Related]
8. Novel substituted naphthalen-1-yl-methanone derivatives as anti-hyperglycemic agents.
Kumar A; Pathak SR; Ahmad P; Ray S; Tewari P; Srivastava AK
Bioorg Med Chem Lett; 2006 May; 16(10):2719-23. PubMed ID: 16500101
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
11. Development and application of rodent models for type 2 diabetes.
Chen D; Wang MW
Diabetes Obes Metab; 2005 Jul; 7(4):307-17. PubMed ID: 15955116
[TBL] [Abstract][Full Text] [Related]
12. Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs.
Hooft van Huijsduijnen R; Sauer WH; Bombrun A; Swinnen D
J Med Chem; 2004 Aug; 47(17):4142-6. PubMed ID: 15293983
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
